References
- Unger P, Clavel MA, Lindman BR, Mathieu P, Pibarot P. Pathophysiology and management of multivalvular disease. Nat Rev Cardiol. 2016;13:429–440.
- Durand E, Doutriaux M, Bettinger N, et al. Incidence, prognostic impact, and predictive factors of readmission for heart failure after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10:2426–2436.
- Urena M, Webb JG,Eltchaninoff H, et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. J Am Coll Cardiol. 2015;65:437–448.
- Petersen JLI, Blackstone EH, Rajeswaran J, et al. Readmission for acute decompensated heart failure among patients successfully treated with transcatheter aortic valve replacement: A PARTNER-1 substudy. Structural Heart. 2018;in press.
- Herrmann HC, Pibarot P, Hueter I, et al. Predictors of mortality and outcomes of therapy in low flow severe aortic stenosis: a PARTNER trial analysis. Circulation. 2013;127:2316–2326.
- Le Ven F, Freeman M, Webb J, et al. Impact of low flow on the outcome of high risk patients undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;62:782–788.
- Dayan V, Vignolo G, Magne J, Clavel MA, Mohty D, Pibarot P. Outcome and impact of aortic valve replacement in patients with preserved LV ejection fraction and low gradient aortic stenosis: a meta-analysis. J Am Coll Cardiol. 2015;66:2594–2603.
- Pibarot P, Weissman NJ, Stewart WJ, et al. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis—A PARTNER trial cohort A analysis. J Am Coll Cardio. 2014;64:1323–1334.
- Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards Sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36:449–456.
- Unger P, Clavel M-A, Lindman BR, Mathieu P, Pibarot P. Pathophysiology and management of multivalvular disease. Nat Rev Cardiol. 2016;13:429–440.
- Jerez-Valero M, Urena M, Webb JG, et al. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation. J Am Coll Cardiol Cardiovasc Interv. 2014;7:1022–1032.
- Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501–H512.
- Doshi D, Burkhoff D. Cardiovascular simulation of heart failure pathophysiology and therapeutics. J Card Fail. 2016;22:303–311.
- Burkhoff D, Dickstein ML, Schleicher T. Harvi - Online. https://harvi.online. 2017. Accessed April 15, 2018.
- Burkhoff D. HARVI: cardiovascular physiology & hemodynamics. Part I. Basic physiological principles (Version 2.0.0) [Mobile application software]. https://itunes.apple.com/gb/app/harvi/id568196279?mt=8. 2014. Accessed April 15, 2018.
- Burkhoff D HARVI: cardiovascular physiology & hemodynamics. Part II. Advanced physiological concepts (Version 2.0.0) [Mobile application software]. https://itunes.apple.com/gb/app/harvi/id568196279?mt=8. 2014. Accessed April 15, 2018.
- Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–1394.
- Angeloni E, Melina G, Pibarot P, et al. Impact of prosthesis-patient mismatch on the regression of secondary mitral regurgitation after isolated aortic valve replacement with a bioprosthetic valve in patients with severe aortic stenosis. Circ Cardiovasc Imaging. 2012;5:36–42.
- Unger P, Magne J, Vanden Eynden F, et al. Impact of prosthesis-patient mismatch on mitral regurgitation after aortic valve replacement. Heart. 2010;96:1627–1632.
- Dupuis M, Mahjoub H, Clavel MA, et al. Forward left ventricular ejection fraction: a simple risk marker in patients with primary mitral regurgitation. J Am Heart Assoc. 2017:6:1–11.
- Gaemperli O, Biaggi P, Gugelmann R, et al. Real-time left ventricular pressure-volume loops during percutaneous mitral valve repair with the MitraClip system. Circulation. 2013;127:1018–1027.
- Maurer MS, Sackner-Bernstein JD, Rumbarger LE, Yushak M, King DL, Burkhoff D. Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure. Circ Heart Fail. 2009;2:189–196.
- Lam CS, Roger VL, Rodeheffer RJ, et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation. 2007;115:1982–1990.
- Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart disease in a swedish nationwide hospital-based register study. Heart. 2017;103:1696–1703.